Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Proteomic and Transcriptomic Profiling Reveals Insights into Mechanisms of Leukemic Immune Escape

Sean I. Tracy, Hrishi Venkatesh, Miriam Arroyo, Todd Knutson, Ashenafi Tilahun, Bartosz Grzywacz, Michael Farrar

Blood (2022) 140 (Supplement 1): 6341–6342.

https://doi.org/10.1182/blood-2022-170683

Published: 2022

Journal Articles

Combining nilotinib and PD-L1 blockade reverses CD4 + T-cell dysfunction and prevents relapse in acute B-cell leukemia

Sean I. Tracy, Hrishi Venkatesh, Can Hekim, Lynn M. Heltemes-Harris, Todd P. Knutson, Veronika Bachanova, Michael A. Farrar

Blood (2022) 140 (4): 335–348.

https://doi.org/10.1182/blood.2021015341

Published: 2022

Includes: Supplemental data

Journal Articles

Characterization of BCR-ABL Specific CD4+ T Cells and Their Role in Controlling Ph+ Acute Lymphoblastic Leukemia

Sean I. Tracy, MD PhD, Can Hekim, MSc,PhD, Michael Farrar, PhD

Blood (2019) 134 (Supplement_1): 1345.

https://doi.org/10.1182/blood-2019-124205

Published: 2019

Journal Articles

Vitamin D Insufficiency Is Associated with an Increased Risk of Early Clinical Failure in Follicular Lymphoma

Sean I. Tracy, MD PhD, Matthew J Maurer, MS, Thomas E. Witzig, MD, Matthew T. Drake, MD PhD, Stephen Ansell, MD PhD, Grzegorz S. Nowakowski, MD, David James Inwards, MD, Carrie A Thompson, MD, Patrick B. Johnston, MD PhD, Ivana Micallef, MD, Cristine Allmer, BS, William R. Macon, MD, George J Weiner, MD, Susan L. Slager, PhD, Thomas M. Habermann, MD, Brian K Link, MD, James R Cerhan, MD PhD

Blood (2016) 128 (22): 1104.

https://doi.org/10.1182/blood.V128.22.1104.1104

Published: 2016

Journal Articles

No Association of EBV or Immunosuppression Status with Outcomes in US Patients with Diffuse Large B-Cell Lymphoma Treated in the Immunochemotherapy Era

Sean I. Tracy, MDPhD, Thomas M. Habermann, MD, Andrew L Feldman, MD, Matthew J Maurer, MS, Ahmet Dogan, Usha S Perepu, MBBS, Sergei Syrbu, MD, Stephen Ansell, MD PhD, Carrie A Thompson, MD, George J Weiner, MD, Cristine Allmer, BS, Susan L. Slager, PhD, Thomas E. Witzig, MD, James R Cerhan, MD PhD, Brian K Link, MD

Blood (2016) 128 (22): 107.

https://doi.org/10.1182/blood.V128.22.107.107

Published: 2016

NARROW

Proteomic and Transcriptomic Profiling Reveals Insights into Mechanisms of Leukemic Immune Escape

Combining nilotinib and PD-L1 blockade reverses CD4 + T-cell dysfunction and prevents relapse in acute B-cell leukemia

Characterization of BCR-ABL Specific CD4+ T Cells and Their Role in Controlling Ph+ Acute Lymphoblastic Leukemia

Vitamin D Insufficiency Is Associated with an Increased Risk of Early Clinical Failure in Follicular Lymphoma

No Association of EBV or Immunosuppression Status with Outcomes in US Patients with Diffuse Large B-Cell Lymphoma Treated in the Immunochemotherapy Era

Email alerts

ASH Publications

American Society of Hematology

Proteomic and Transcriptomic Profiling Reveals Insights into Mechanisms of Leukemic Immune Escape

Combining nilotinib and PD-L1 blockade reverses CD4 + T-cell dysfunction and prevents relapse in acute B-cell leukemia

Characterization of BCR-ABL Specific CD4+ T Cells and Their Role in Controlling Ph+ Acute Lymphoblastic Leukemia

Vitamin D Insufficiency Is Associated with an Increased Risk of Early Clinical Failure in Follicular Lymphoma

No Association of EBV or Immunosuppression Status with Outcomes in US Patients with Diffuse Large B-Cell Lymphoma Treated in the Immunochemotherapy Era

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only